FDA Puts Clinical Hold on Three CARsgen Therapeutics CAR-T Candidates

The FDA has placed a clinical hold on three of CARsgen Therapeutics’ CAR-T cell therapy candidates following an inspection of the Chinese biotech’s manufacturing facility in Durham, North Carolina.